The company offers surgical robotics with catheter-based technology and implants to repair and replace heart valves. It will use the funds to advance its reach within healthcare. "Percutaneous ...

Capstan Medical has raised $110 million in a series C round to bring its robotic-enabled minimally invasive solutions to address heart valve disease to market. This follows a $31.4 million round the ...

Capstan Medical has reeled in $110 million to continue its mission of bringing robotic surgery to a previously untouched sector of medicine: the replacement of cardiac valves to treat structural heart ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Santa Cruz startup Capstan ...

Capstan Medical Inc. closed an oversubscribed series C fundraising round that brought in $110 million for the structural heart-focused company. Capstan aims to combine valve implants, advanced ...